AzTrials
AzTrials

Refractive ErrorNCT02066922

A Comparative Study of Two Daily Disposable Contact Lenses in Higher Myopia Subjects

A study testing Delefilcon A contact lens, Narafilcon A contact lens and Spectacles in people with Refractive Error and Myopia, run by Alcon Research.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the change from baseline in central corneal curvature at one week, between 2 silicone hydrogel lenses, in higher myopic subjects. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Refractive Error, Myopia
What is being tested?
Delefilcon A contact lens, Narafilcon A contact lens and Spectacles
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
No sites listed yet
Study dates
Mar 2014to May 2014
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Sign Informed Consent document;
  • Higher degree of myopia in both eyes, i.e. habitual contact lens power between -10.00 diopters (D) and -17.00D;
  • Best corrected distance visual acuity greater than or equal to 20/30 in each eye (measured with either spectacle refraction or habitual contact lenses plus over refraction);
  • Manifest astigmatism less than or equal to -1.00D;
  • Soft contact lens wear in both eyes at least 5 days per week and at least 8 hours per day;
  • Other protocol-defined inclusion criteria may apply.

Who cannot join

  • Pregnant or lactating;
  • Eye injury or surgery within twelve weeks immediately prior to enrollment;
  • Any ocular condition that contraindicates contact lens wear;
  • History of herpetic keratitis;
  • Any use of systemic or ocular medications for which contact lens wear could be contraindicated, including any use of topical ocular medications that would require instillation during contact lens wear, except for approved lubricating drops;
  • Clinical significant dry eye not responding to treatment;
Show all 11Show fewer
  • Previous corneal or refractive surgery or irregular cornea;
  • Requires reading glasses;
  • Participation in a clinical trial (including contact lens or contact lens care product) within the previous 30 days;
  • Wears habitual lenses in an extended wear modality (routinely sleeps in lenses overnight for 1 night per week or more) over the last 3 months prior to enrollment;
  • Other protocol-defined exclusion criteria may apply.

About this study

The purpose of this study is to compare the change from baseline in central corneal curvature at one week, between 2 silicone hydrogel lenses, in higher myopic subjects.

Read the detailed description

Participants were expected to attend 4 office visits. Visit 1 was the Screening/Enrollment visit. At Visit 2 (Baseline Visit), participants were randomized and the study lenses were trial fit. At Visit 3 (Dispense Visit), participants received study lenses for approximately 1 week of wear. Visit 4 was the Exit visit. Expected duration of participation in the study was 3 weeks.

Being tested
Delefilcon A contact lens, Narafilcon A contact lens, Spectacles
Keywords
Contact lenses, Nearsightedness, Corneal curvature, K-reading, High minus, Spectacle refraction
Medical subject headings
Refractive Errors, Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Delefilcon A contact lensDevice

    Also called DAILIES® TOTAL1®

    Commercially available silicone hydrogel contact lens

  • Narafilcon A contact lensDevice

    Also called 1-DAY ACUVUE TRUEYE™

    Commercially available silicone hydrogel contact lens

  • SpectaclesDevice

    Incremental prescription worn over contact lenses if needed to provide acceptable vision

Study groups in NCT02066922
Study groupRoleWhat they receive
DAILIES TOTAL1ExperimentalDelefilcon A contact lens randomly assigned to one eye, with narafilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.
Receives: Device: Delefilcon A contact lens; Device: Narafilcon A contact lens; Device: Spectacles
TRUEYEActive comparatorNarafilcon A contact lens randomly assigned to one eye, with delefilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.
Receives: Device: Delefilcon A contact lens; Device: Narafilcon A contact lens; Device: Spectacles

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Average Central Corneal Curvature From Dispense at Week 1

    Corneal curvature (horizontal and vertical keratometry values on the same eye) was measured using a calibrated keratometer prior to study lens dispense (Day 1) and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Minus values in change-from-baseline indicate corneal flattening.

    Measured: Dispense (Day 1 of lens wear), Week 1 (Day 8 of lens wear)

Secondary outcomes (1)
  1. Number of Eyes With Change of >1.00 Diopter (D) in Spherical Equivalent of Subjective Refraction From Baseline at Week 1

    Subjective manifest refraction was assessed using a phoropter or trial frame set with the subject's current prescription at Baseline (Visit 2) after a 2-day washout period and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Spectacle over-refraction, if required, was performed. Higher myopia is indicated by larger negative values in manifest refraction.

    Measured: Baseline, Week 1 (Day 8 of lens wear)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2014 (estimated)
  2. Study startMar 2014
  3. Primary completionMay 2014
  4. Study completionMay 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02066922
Sponsor's protocol ID
C-12-057
Status last verified
May 2015
First submitted
8 Aug 2013
Last updated
8 Jun 2015
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Delefilcon A contact lens, Narafilcon A contact lens and Spectacles in people with Refractive Error and Myopia, run by Alcon Research.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 Jun 2015). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Average Central Corneal Curvature From Dispense at Week 1 (time frame: Dispense (Day 1 of lens wear), Week 1 (Day 8 of lens wear)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in